series-a
Stage
2018
Founded
2
Investors
About
RhyGaze AG is a biotechnology company focused on developing gene therapies for retinal diseases causing blindness, utilizing optogenetic proteins and gene therapy tools to restore vision.
Explore RhyGaze AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.